1. Dementia: assessment, management and support for people living with dementia and theircarers. NICE (The National Institute for Health and Care Excellence) guideline. 2018. URL:https://www.nice.org.uk/guidance/ng97/resources/dementia-assessment-managementand-support-for-people-living-with-dementia-and-their-carers-pdf-1837760199109 (date ofaccess – 12.11.2020). 2. World Health Organization. International statistical classification of diseases and relatedhealth problems 10th revision. URL: https://icd.who.int/browse10/2019/en (date of access –12.11.2020). 3. Гаврилова С.И. Психиатрия. Научно-практический справочник. Под ред. А.С.Тиганова. М.: Медицинское информационное агентство. 2016; 608 с. 4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders:DSM-5. 5th ed. Washington DC: APA. 2013; 917 p. 5. Когнитивные нарушения. Методические рекомендации. M.: Департамент здравоохранения города Москвы. 2019; 48 с. 6. Lorentz W.J., Scanlan J.M., Borson S. Brief screening tests for dementia. Can J Psychiatry.2002; 47(8): 723–33. doi: 10.1177/070674370204700803. 7. Pfeffer R.I., Kurosaki T.T., Harrah C.H. Jr., et al. Measurement of functional activities inolder adults in the community. Journal of Gerontology. 1982; 37(3): 323–29. doi: 10.1093/geronj/37.3.323. 8. Jorm A.F., Jacomb P.A. The Informant Questionnaire on Cognitive Decline in the Elderly(IQCODE): Socio-demographic correlates, reliability, validity and some norms. PsychologicalMedicine. 1989; 19: 1015–22. doi: 10.1017/s0033291700005742. 9. Программа профилактики, раннего выявления, диагностики и лечения когнитивныхрасстройств у лиц пожилого и старческого возраста: методические рекомендации. Подред. О.Н. Ткачевой. М.: Прометей. 2019; 72 с. 10. World Health Organization. Dementia. A public health priority. 2012. URL: https://apps.who.int/iris/bitstream/handle/10665/75263/9789241564458_eng.pdf?sequence=1&isAllowed=y(date of access – 12.11.2020). 11. Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease.NICE (The National Institute for Health and Care Excellence) technology appraisal guidance.2011. URL: https://www.nice.org.uk/guidance/ta217/resources/donepezil-galantaminerivastigmine-and-memantine-for-the-treatment-of-alzheimers-disease-pdf-82600254699973(date of access – 12.11.2020). 12. Kishi T., Matsunaga S., Oya K. et al. Memantine for Alzheimer's disease: An updated systematicreview and meta-analysis. J Alzheimers Dis. 2017; 60(2): 401–25. doi: 10.3233/JAD-170424.